Cullinan Oncology, Inc. (CGEM) Stock Surges Following Positive Supplementary CLN-081 Study Information
Cullinan Oncology, Inc. (CGEM) stock prices were up by 18.63% shortly after market trading commenced on June 4th, 2021, bringing the price per share up to USD$35.30 early on in the trading day. CLN-081 Trial Update The oncology company announced supplementary information about Cullinan Pearl’s ongoing Phase 1/2a trial of CLN-081 on June 4th, 2021. […]
How come Cullinan Management, Inc.’s (CGEM) stock is performing so well right now?
Cullinan Management, Inc. (CGEM) stock soared 33.33% to $28.00 as the biotech company announced the pricing of its upsized initial public offering that will distribute 11,900,000 shares of the Company’s common stock to the public at a price of $21.00 per share. Before deducting underwriting discounts, commissions, and other offering expenses, Cullinan Management expects to […]
